A. Napoli

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation

T. Brown, G. McComsey, M. Yin, 2015, Annals of Internal Medicine.

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation

T. Brown, G. McComsey, M. Yin, 2017, AIDS.

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial

B. Strober, A. Gottlieb, M. Gooderham, 2022, Dermatology and Therapy.

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post‐liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real‐world cohort

K. Reddy, P. Kwo, M. Fried, 2018, Hepatology communications.

No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database

H. Tilson, D. Seekins, A. Napoli, 2014, Journal of the International AIDS Society.

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial

M. Ohtsuki, A. Napoli, E. Colston, 2024, The Journal of dermatology.